Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular interferon beta-1a therapy: a pilot study

By Brandes David W.   Bigley Kim   Hornstein William   Cohen Hart   Au William   Shubin Richard  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1667-1672

Informa Healthcare

Access to resources Recommend Favorite

Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation

By Matson Mark A.   Zimmerman Thomas R.   Tuccillo Dianne   Tang Yongqiang   Deykin Aaron  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

By Castelli-Haley Jane  

Advances in Therapy, Vol. 25, Iss. 8, 2008-08 ,pp. : 830-830

Springer Publishing Company

Access to resources Recommend Favorite

A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden

By Fredrikson Sten  

Journal of Medical Economics, Vol. 16, Iss. 6, 2013-06 ,pp. : 756-762

Informa Healthcare

Access to resources Recommend Favorite

Interferon beta‐1b‐induced Sweet's syndrome in a patient with multiple sclerosis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 4, 2015-04 ,pp. : 456-458

John Wiley & Sons Inc

Access to resources Recommend Favorite